“Trial in Progress: A Phase 3 Randomized Study of Low-Dose Intralesional Cemiplimab Versus Primary Surgery for Patients With Early-Stage Cutaneous Squamous Cell Carcinoma (CLEAR CSCC)”. 2025. SKIN The Journal of Cutaneous Medicine 9 (6): s689. https://doi.org/10.25251/cpgrax68.